Trial Profile
A Open-label, Single Center Drug Interaction Study of Morphothiadine Mesilate/Ritonavir , Entecavir and Tenofovir Disoproxil Fumarate in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Morphothiadine (Primary) ; Ritonavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sunshine Lake Pharma
- 08 Oct 2019 Status changed from recruiting to completed.
- 17 Sep 2018 New trial record